This is not the most recent version of the article. View current version (10 OCT 2013)

Intervention Protocol

You have free access to this content

Optimal time for initiating antiretroviral therapy (ART) in HIV-positive, treatment-naive children aged 24 to 59 months (2 to 5 years old)

  1. Nandi Siegfried1,*,
  2. Matthias Egger2,
  3. Mary-Ann Davies3,
  4. Martina Penazzato4

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 28 MAR 2013

Assessed as up-to-date: 6 SEP 2012

DOI: 10.1002/14651858.CD010309


How to Cite

Siegfried N, Egger M, Davies MA, Penazzato M. Optimal time for initiating antiretroviral therapy (ART) in HIV-positive, treatment-naive children aged 24 to 59 months (2 to 5 years old) (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD010309. DOI: 10.1002/14651858.CD010309.

Author Information

  1. 1

    University of Cape Town, Department of Psychiatry and Mental Health, Faculty of Health Sciences, Cape Town, South Africa

  2. 2

    Institute of Social and Preventive Medicine, Institute of Social Medicine, Bern, Switzerland

  3. 3

    School of Public Health and Family Medicine, Centre for Infectious Disease Epidemiology and Research (CIDER), Cape Town, South Africa

  4. 4

    World Health Organization, Geneva, Switzerland

*Nandi Siegfried, Department of Psychiatry and Mental Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. nandi.siegfried@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 28 MAR 2013

SEARCH

This is not the most recent version of the article. View current version (10 OCT 2013)

References

Additional references

DAIDS 2009
  • Division of AIDS. Table for grading the severity of Adult and Pediatric Adverse Events. Accessed 28 October 2009 http://rcc.tech-res.com/Document/safetyandpharmacovigilance/DAIDS_AE_GradingTable_Clarification_August2009_Final.pdf.
GradePro 2008
  • Jan Bozek, Andrew Oxman, Olger Schunemann. GradePro 2008. 3.2 for Windows. GRADE Working Group, 2008, 2008.
Guyatt 2011
  • Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology 2011;64(4):383-94. [PUBMED: 21195583]
Heidari 2012
  • Heidari S, Mofenson LM, Hobbs CV, Cotton MF, Marlink R, Katabira E. Unresolved antiretroviral treatment management issues in HIV-infected children. Journal of acquired immune deficiency syndromes (1999) 2012;59(2):161-9. [PUBMED: 22138766]
Higgins 2002
Higgins 2009
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org.
Patel 2008
  • Patel K, Hernan MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(4):507-15. [PUBMED: 18199042]
Penazzato 2012
  • Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Cochrane database of systematic reviews (Online) 2012;7:CD004772. [PUBMED: 22786492]
Prendergast 2012
  • Prendergast AJ, Penazzato M, Cotton M, Musoke P, Mulenga V, Abrams EJ, Gibb DM. Treatment of Young Children with HIV Infection: Using Evidence to Inform Policymakers. PLoS Medicine 2012;9(7):e1001273. doi:10.1371/journal.pmed.1001273.
Robins 2000
UNAIDS 2010
  • Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010.. http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf 2010; Vol. (Accessed 30 July 2012).
Violari 2008
  • Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA, CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Eng J Med 2008;359:2233–2244.
WHO 2002
  • World Health Organization. Scaling up antiretroviral therapy In resource-limited settings: guidelines for a public health approach. 2002; Vol. http://www.who.int/hiv/pub/prev_care/en/ScalingUp_E.pdf (Accessed 29 July 2012).
WHO 2003
  • World Health Organization. Scaling up antiretroviral therapy in resource-limited settings:treatment guidelines for a public health approach [2003 revision]. 2003; Vol. http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf (Accessed 29 July 2012).
WHO 2006a
  • World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach [2006 revision]. World Health Organization, 2006; Vol. http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf (Accessed 29 July 2012).
WHO 2006b
  • World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2006; Vol. http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf (Accessed 29 July 2012).
WHO 2010a
  • World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf (Accessed 29 July 2012).
WHO 2010b
  • World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf (Accessed 29 July 2012).
WHO 2011a
  • World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. 2011; Vol. http://whqlibdoc.who.int/publications/2011/9789241502986_eng.pdf (Accessed 2 August 2012).
WHO 2011b
  • World Health Organization. The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. 2011; Vol. http://whqlibdoc.who.int/publications/2011/9789241501934_eng.pdf (Accessed 2 August 2012).